04.06.2013 Views

Prearranged Glycosides, Part 12, Intramolecular Mannosylations of ...

Prearranged Glycosides, Part 12, Intramolecular Mannosylations of ...

Prearranged Glycosides, Part 12, Intramolecular Mannosylations of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Helvetica Chimica Acta ± Vol. 83 2000) 2669<br />

CH 2Cl 2, and filtered. The filtrate was washed with H 2O, dried, and evaporated. CC toluene/acetone 20 :1) <strong>of</strong><br />

the residue afforded 18a/18b 17 : 83 0.26 g, 64%).<br />

f) As described in Exper. e, with 17b 0.55 g, 0.53 mmol), 4-Š molecular sieves 1.32 g), MeOTf 0.40 ml,<br />

3.7 mmol), and MeCN 20 ml), followed by CC toluene/acetone 20 : 1): 18a 0.33 g, 64%).<br />

Benzyl O-3-O-Benzoyl-2,4,6-tri-O-benzyl-a-d-mannopyranosyl)-1 ! 4)-2,3-di-O-benzoyl-6-O-benzyl-ad-glucopyranoside<br />

19a) and Benzyl O-3-O-Benzoyl-2,4,6-tri-O-benzyl-b-d-mannopyranosyl)-1 ! 4)-2,3-di-<br />

O-benzoyl-6-O-benzyl-a-d-glucopyranoside 19b). a) As described for 7, with 18a 111 mg, 0.11 mmol),<br />

NaOMe in MeOH 4 ml), BzCl 79 ml, 0.68 mmol), and pyridine 4 ml): 19a 92 mg, 73%). [a] D ˆ‡43.6 c ˆ<br />

1.82, CHCl 3). 1 H-NMR CDCl 3): 6.10 dd, J3,4) ˆ 9.2, H C3)); 5.60 dd, J3',4') ˆ 9.4, H C3')); 5.33<br />

d, J1,2) ˆ 3.8, H C1)); 5.19 dd, J2,3) ˆ 10.3, H C2)); 5.14 d, J1',2') ˆ 1.8, H C1')); 4.74 d, J ˆ <strong>12</strong>.5,<br />

1 H, PhCH 2); 4.75d, J ˆ <strong>12</strong>.5, 1 H, PhCH 2); 4.65d, J ˆ <strong>12</strong>.7, 1 H, PhCH 2); 4.62 d, J ˆ <strong>12</strong>.3, 1 H, PhCH 2);<br />

4.60 ± 4.55 m, 2 H, PhCH 2); 4.45± 4.40 m, 2 H, PhCH 2); 4.40 t, J4',5') ˆ 9.5, H C4')); 4.19 d, J ˆ 11.9,<br />

1 H, PhCH 2); 4.13 t, J4,5) ˆ 9.3, H C4)); 4.<strong>12</strong> d, J ˆ <strong>12</strong>.1, 1 H, PhCH 2); 4.03 ± 3.98 m, J5,6a) ˆ 4.1,<br />

J5,6b) ˆ 2.0, H C5)); 3.95 dd, J6a,6b) ˆ 11.2, H a C6)); 3.86 ± 3.80 m, J5',6b') ˆ 3.1, H C5'),<br />

H a C6')); 3.84 dd, J2',3') ˆ 3.0, H C2')); 3.74 dd, J6a',6b') ˆ 11.6, H b C6')); 3.73 dd, H b C6)).<br />

13 C-NMR CDCl3): 165.6, 165.5, 165.4 PhCO); 98.8 J1', H C1')) ˆ 170.9, C1')); 95.1 C1)); 77.7 C2'));<br />

76.3 C4)); 75.6 C4')); 74.7 PhCH 2); 74.1 PhCH 2); 73.9, 73.7, 73.51 C, 1 C, 2 C, C5'),C3),C3'),PhCH 2);<br />

72.7 PhCH 2); 72.4 C2)); 70.2 C5)); 69.8 PhCH 2); 68.8 C6')); 68.5C6)). Anal. calc. for C 68H 64O 14<br />

1105.25): C 73.90, H 5.84; found: C 74.05, H 5.93.<br />

b) As described for 7, with 18b 159 mg, 0.16 mmol), NaOMe, MeOH 4 ml), BzCl 113 ml, 0.98 mmol), and<br />

pyridine 4 ml): 19b 130 mg, 72%). [a] D ˆ 32.3 c ˆ 1.10, CHCl 3). 1 H-NMR CDCl 3): 6.10 t, J3,4) ˆ 9.8,<br />

H C3)); 5.34 d, J1,2) ˆ 3.8, H C1)); 5.21 dd, J2,3) ˆ 10.2, H C2)); 5.00 dd, H C3')); 4.76 d, J ˆ<br />

<strong>12</strong>.6, 1 H, PhCH 2); 4.75d, J ˆ <strong>12</strong>.5, 1 H, PhCH 2); 4.71 d, J ˆ <strong>12</strong>.7, 1 H, PhCH 2); 4.60 d, J ˆ <strong>12</strong>.9, 1 H,<br />

PhCH 2); 4.60 ± 4.52 m, 3 H, PhCH 2); 4.44 s, H C1')); 4.43 d, J ˆ <strong>12</strong>.1, 1 H, PhCH 2); 4.42 d, J ˆ 11.8,<br />

1 H, PhCH 2); 4.33 t, J4,5) ˆ 9.8, H C4)); 4.15d, J ˆ 11.8, 1 H, PhCH 2); 4.05± 3.99 m, J5,6a) ˆ 2.8,<br />

J5,6b) ˆ 1.8, H C5)); 4.00 t, J4',5') ˆ 9.7, H C4')); 3.89 br. d, J2',3') ˆ 3.1, H C2')); 3.74<br />

dd, J6a,6b) ˆ 11.2, H C6a)); 3.66 dd, H b C6)); 3.44 dd, J6a',6b') ˆ 11.4, H a C6')); 3.34<br />

dd,H b C6')); 3.26 ± 3.21 m, J5',6a') ˆ 4.5, J5',6b') ˆ 1.8, H C5')). 13 C-NMR CDCl 3): 165.7, 165.6 1 C,<br />

2C,PhCO); 100.6 J1', H C1')) ˆ 158.5, C1')); 95.3 C1)); 76.2, 76.0 1 C, 2 C, C2'), C3'), C5')); 74.9<br />

C4)); 74.6 PhCH 2); 74.3 PhCH 2); 73.7 PhCH 2); 73.1 PhCH 2); 73.0 C4')); 72.2 C2)); 70.9, 70.2 C3),<br />

C5)); 69.8 PhCH 2); 68.8 C6')); 68.1 C6)). Anal. calc. for C 68H 64O 14 1105.25): C 73.90, H 5.84; found:<br />

C 74.10, H 5.90.<br />

c) As described for 7, with 18a/18b 1 : 9 see above, Exper. c; 0.20 g, 0.2 mmol), NaOMe in MeOH 8 ml),<br />

BzCl 139 ml, 1.2 mmol), and pyridine 8 ml), followed by CC hexane/AcOEt 5: 1): 19a 14 mg, 7%) and 19b<br />

141 mg, 64%).<br />

d) As described for 7, with 18a/18b 17 : 83 see above, Exper. e; 0.18 g, 0.18 mmol), NaOMe in MeOH<br />

8 ml), BzCl <strong>12</strong>6 ml, 1.1 mmol), and pyridine 8 ml), followed by CC hexane/AcOEt 5:1): 19a 23 mg, <strong>12</strong>%)<br />

and 19b 105mg, 58%).<br />

Ethyl 2,4,6-Tri-O-benzyl-3-O-[3-tert-butoxy)-1,3-dioxopropyl]-1-thio-a-d-mannopyranoside 20). A soln.<br />

<strong>of</strong> 14b 1.78 g, 4.54 mmol), tert-butyl hydrogen malonate 0.61 g, 3.78 mmol), 1-hydroxy-1H-benzotriazole<br />

0.61 g, 4.54 mmol), and DCC 0.78 g, 3.78 mmol) in CH 2Cl 2 30 ml) was stirred for 1 h at 08 followed by 48 h at<br />

r.t. Workup as described for 4a and CC hexane/AcOEt 8 :1) afforded 20 1.50 g, 62%). [a] D ˆ‡51.4 c ˆ 1.83,<br />

CHCl 3). 1 H-NMR CDCl 3): 5.35 d, J1,2) ˆ 1.8, H C1)); 5.27 s, PhCH); 5.22 dd, J3,4) ˆ 9.1, H C3));<br />

4.68 d, J ˆ <strong>12</strong>.0, 1 H, PhCH 2); 4.67 d, J ˆ <strong>12</strong>.0, 1 H, PhCH 2); 4.66 d, J ˆ 11.1, 1 H, PhCH 2); 4.58 d, J ˆ<br />

<strong>12</strong>.0, 1 H, PhCH 2); 4.48 d, J ˆ <strong>12</strong>.0, 1 H, PhCH 2); 4.46 d, J ˆ 11.1, 1 H, PhCH 2); 4.18 ddd, J5,6a) ˆ 4.2,<br />

J5,6b) ˆ 1.9, H C5)); 4.09 t, J4,5) ˆ 9.5, H C4)); 3.99 dd, J2,3) ˆ 3.3, H C2)); 3.82 dd, J6a,6b) ˆ<br />

11.0, H a C6)); 3.68 dd, H b C6)); 3.18 br. d, COCH 2); 2.67 ± 2.51 m, MeCH 2S); 1.42 s, t Bu); 1.24 t, J ˆ<br />

7.4, MeCH 2S). 13 C-NMR CDCl 3): 166.2 COCH 2); 165.4 COCH 2); 82.1 Me 3C); 81.7 C1)); 77.3 C2)); 75.1<br />

C3)); 74.5PhCH 2); 73.4 C4)); 73.3 PhCH 2); 72.4 PhCH 2); 71.7 C5)); 68.8 PhCH 2); 63.6 C6)); 42.7<br />

COCH 2); 27.9 Me 3C); 25.1 MeCH 2S); 14.8 MeCH 2S). Anal. calc. for C 36H 44O 8S 636.80): C 67.90, H 6.96,<br />

S 5.04; found: C 67.58, H 6.92, S 5.06.<br />

Ethyl 2,4,6-Tri-O-benzyl-3-O-carboxyacetyl)-1-thio-a-d-mannopyranoside 21). A soln. <strong>of</strong> 20 1.25g,<br />

1.96 mmol) and CF 3COOH 4.3 ml, 37.2 mmol) in CH 2Cl 2 40 ml) was stirred for 3 h at r.t. Evaporation afforded<br />

crude 21 1.08 g, 95%), which was used without further purification in the next step.<br />

Benzyl 2-O-Benzoyl-4,6-O-benzylidene-3-O-[3-ethyl 2,4,6-tri-O-benzyl-1-thio-a-d-mannopyranosid-3-Oyl)-1,3-dioxopropyl]-a-d-glucopyranoside<br />

22). As described for 4a, with crude 21 1.08 g, 1.9 mmol), 3 [26]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!